Mional Tablet (Eperisone Hydrochloride)

Adult dose

As Eperisone Hydrochloride, take 50 mg orally three times a day after meals. Adjust dosage appropriately based on age and symptoms.

This medication should not be used in certain patients. Particularly, it should not be administered to patients with hypersensitivity to this medication or those with severe myasthenia gravis. Caution should be exercised in patients with a history of hypersensitivity to the drug or with liver function issues. Regular monitoring of liver function is necessary as liver function may deteriorate. Allergic reactions may occur during the use of this medication. If symptoms such as rash, itching, hives, swelling of the face or other areas, or difficulty breathing occur, treatment should be stopped immediately, and medical attention should be sought. Serious skin conditions such as toxic epidermal necrolysis or Stevens-Johnson syndrome may occur, so it is important to closely observe for symptoms such as fever, skin rash, blisters, itching, eye redness, and stomatitis. Symptoms of liver function impairment may also occur rarely, so liver enzymes should be checked to monitor the condition. Renal dysfunction symptoms, such as proteinuria or elevated blood urea nitrogen (BUN), should also be observed, and if any abnormalities are found, administration should be discontinued. Blood abnormalities such as anemia may also occur sporadically, so if symptoms arise, immediate consultation with a physician is necessary. Allergic reactions such as skin rash or itching, and polymorphous exudative erythema may occur. Neurological side effects may include insomnia, drowsiness, headache, limb paralysis, stiffness, and tremors. Gastrointestinal disturbances may present as nausea, vomiting, loss of appetite, discomfort in the stomach, thirst, constipation, diarrhea, and abdominal pain. Urinary side effects, such as urinary retention, incontinence, and feelings of residual urine may occur rarely. Systemic symptoms including weakness, staggering, general malaise, dizziness, and muscle tone reduction have been reported. Additionally, symptoms such as facial flushing, sweating, swelling, palpitations, and hiccups may present. If weakness, staggering, or drowsiness occurs during administration, the dosage should be reduced or the medication should be stopped. This medication can cause drowsiness or reduced attention, so driving or operating hazardous machinery should be avoided. Caution should be exercised when taken in conjunction with similar drugs such as tolperisone hydrochloride or methocarbamol, as visual disturbance may occur. Women who are pregnant or may become pregnant should use this medication only when the benefits of treatment outweigh the risks. Nursing mothers are advised to avoid this medication, and if unavoidable, they should cease breastfeeding. The safety of this medication in children has not been sufficiently established, so caution is required for use in this population. Elderly patients may have reduced body function, so the dosage should be adjusted and used cautiously.

Serious side effects

• Hives
• severe swelling
• difficulty breathing
• shock or anaphylactic-like reactions
• toxic epidermal necrolysis
• mucocutaneous syndrome
• Stevens-Johnson syndrome
• rash
• itching
• swelling of the face or other areas

Mild side effects

• Rash
• itching
• swelling of the face or other areas
• fever
• erythema
• itching
• eye redness
• stomatitis
• elevated ALT
• AST

This medication should be stored in a sealed container to prevent air or moisture from entering. It should be kept at room temperature, specifically between 1 to 30 degrees Celsius, to maintain its effectiveness.

Appearance

Green convex round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle